{
    "nctId": "NCT02835781",
    "briefTitle": "Acellular Dermal Matrix in Breast Reconstruction",
    "officialTitle": "Allogenic Acellular Dermal Matrix Use in Patients With Breast Reconstruction",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Number of complications in patients receiving acellular dermal matrix evaluated at 6 months after primary implantation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* signed informed consent\n* total one-side mastectomy due to breast cancer\n* age between 18-60 years\n\nExclusion Criteria:\n\n* failure to obtain signed informed consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}